00:00
Let's talk a bit about cancer stem cells because, I guess, they said this would become a
popular topic. So a normal stem cell has the capacity to regenerate itself and a daughter
cell with different characteristics. That is the nature of stemness, so you will have
self-replication of another stem cell, but then you can have precursor cells or progenitor
cells that go on to form the adult tissues. Okay, so that's what we talk about with a normal
stem cell. In malignancy, one of the current hypothesis is that it's not the progenitor cells,
it's not the cells further down the proliferation pathway that become malignant, but rather
it's the stem cell itself that acquires malignant potential that has all mutations. And then
the tumor cells, its progeny, its daughter cells are also going to be carcinogenic because
they've had the mutations in proto-oncogenes or tumor suppressor genes and we get a
bulk tumor that is mostly of the progenitor cells with a few of the stem cells kind of lurking
there in the shadows. Okay, but the primary malignancy, the primary mutagenic change,
the primary thing that cause cancer happen in the stem cell population not in the daughter
cells. So, fundamentally what this is saying is that, and again keep in mind this is a
heterogenous tumor, with any given tumor there are cells within it, a very small population
that have the capacity to initiate and sustain the tumor. Those are the tumor stem cells.
01:40
Importantly, stem cells in general have a very low rate of replication. They don't do that
cell cycle thing very often so as a consequence they're going to be resistant to cell cycle
drugs. It kind of makes sense. If a cell is rapidly turning over almost any agent that we throw
into the works that can inhibit that cell cycle replication is going to be very effective.
02:04
But if I dump a bunch of chemotherapy on top of a cancer stem cell that's only periodically
burping out a daughter cell, most of the time when the chemo is there it's not going to be
having any effect because its cell is not turning over. So this hypothesis about cancer
stem cells being a small population that's residual within the bulk tumor can explain
resistance to chemotherapy. And it maybe a way to explain how some tumors can have
a late recurrence even after the bulk of the malignancy is gone. It's because we haven't
treated the stem cells. So, other ways to think about this or additional kind of concepts
that come out of this primary hypothesis. So you have normal stem cells. There are
mutations, you have a new cancer stem cell, and then as we saw on the previous slide that
will have progeny, there will be a bulk tumor, that's the primary tumor, with few stem cells
kind of lurking in the shadows. If we have then chemotherapy of that, we may either have
refractory cancer or cancer that comes back. That's because the stem cells are relatively
resistant to the chemotherapy because they're not turning over avidly. And, you can also
have tumor cell escape from the primary tumor so if metastasis may not be the daughter
cells that are causing kind of tumor at a distance but rather that stem cell becomes able to
circulate and can set up new tumors everywhere else. So this is where we need to step
back and think for a little bit though, about this hypothesis regarding stem cells. So at the
top you see the stem cell, it's self-renewing and then it has an asymmetric division after it
makes one of itself again that asymmetric division leads to the daughter cells. And the
daughter cells will proliferate those of the progenitor cells and eventually will get our final
population. That's the way it's supposed to work and there's no cancer here yet. Over here
we have cancer cells. Did they come from that self-renewing stem cell at the top or does
the stemness or apparent stemness of a tumor population come from acquired features
that make tumor cells, the progenitor cells, look like their stem cells. And we actually don't
really know which of the 2 cases is happening. Needless to say though, if you acquire stem
cell features, you will be a slowly turning over cell that is not prone to chemotherapy
effects. So kind of important thing to keep in mind.